Today: 17 June 2026

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Nuburu Stock Soars on New Defense Deals – Price, News, and Expert Analysis

Nuburu Stock Soars on New Defense Deals – Price, News, and Expert Analysis

Nuburu shares tripled to $0.36 by mid-day Oct 22, following a joint venture announcement with Maddox Defense targeting military and commercial drones. The company recently agreed to buy Italy’s Orbit S.r.l. for $12.5 million and secured a $6.6 million order via a new JV with Tekne. Despite recent deals and a $12 million capital raise, Nuburu remains unprofitable, with Q2 revenue at $49,000 and a $12.2 million net loss.
AI Buzz Lifts Pegasystems Stock – Pega Shares Soar on Strong Q3 Results and New Platform Launch

AI Buzz Lifts Pegasystems Stock – Pega Shares Soar on Strong Q3 Results and New Platform Launch

Pega shares rose to $57 on Oct. 21, 2025, after Q3 revenue hit $381.4 million, up 17% year-over-year, and adjusted EPS reached $0.30, beating forecasts. Annual Contract Value climbed 14% to $1.56 billion, with Pega Cloud ACV up 27%. The company generated $347 million in operating cash and repurchased 8.7 million shares this year. Analysts raised price targets, citing strong AI-driven product momentum.
Avadel Stock Rockets on $2.1B Alkermes Buyout Offer – Key Developments & Analyst Takeaways

Avadel Stock Rockets on $2.1B Alkermes Buyout Offer – Key Developments & Analyst Takeaways

Alkermes will acquire Avadel for $18.50 per share in cash, plus a $1.50 contingent payout, valuing the deal at about $2.1 billion. Avadel’s LUMRYZ sales are projected at $265–$275 million in 2025, with 3,100 patients on therapy. AVDL shares surged to near a 52-week high after the Jazz settlement and Alkermes news. Halper Sadeh LLC is investigating whether the offer undervalues Avadel.
Amphenol (APH) Stock Soars on Record Q3 and AI Boom – Analysts Target $150

Amphenol (APH) Stock Soars on Record Q3 and AI Boom – Analysts Target $150

Amphenol shares surged to $125–$128 in mid-October 2025, up about 80% year-to-date, after Q3 sales jumped 53% to $6.2 billion and EPS rose 86% to $0.93, beating forecasts. The company raised full-year guidance, projecting up to $22.76 billion revenue and $3.28 EPS. Recent acquisitions and strong AI sector demand fueled growth. APH spiked 9% post-earnings, with analysts raising price targets.
Applied DNA (BNBX) Stock Surges on $58M Binance BNB Crypto Bet; New Ticker Takes Effect

Applied DNA (BNBX) Stock Surges on $58M Binance BNB Crypto Bet; New Ticker Takes Effect

Applied DNA Sciences (Nasdaq: BNBX) closed a private placement for up to $58 million to fund a BNB-focused digital asset treasury, receiving $27 million immediately. The company now holds over 15,500 BNB tokens and rebranded as BNBX on Oct. 7. BNBX stock rose to $4.49 on Oct. 22, up from $3.42 the previous day. Anthony Scaramucci joined as adviser; Clay Shorrock was named CEO.
Arcturus Therapeutics Stock Soars to New High Then Crashes on Trial Data – What Investors Need to Know

Arcturus Therapeutics Stock Soars to New High Then Crashes on Trial Data – What Investors Need to Know

Arcturus stock hit a 52-week high of $24.17 on Oct. 21 before plunging up to 60% after mixed Phase 2 cystic fibrosis trial results. Interim data showed ARCT-032 was generally safe and reduced lung mucus in most patients, but failed to improve primary lung-function measures. A higher-dose cohort is underway. Analyst ratings remain moderately positive, with price targets averaging $50.
22 October 2025
Beneficient (BENF) Stock Skyrockets 64% After CEO Converts $52M Preferred into Common

Beneficient (BENF) Stock Skyrockets 64% After CEO Converts $52M Preferred into Common

Beneficient stock surged 64% to $0.80 after hours Oct. 21 following Chairman Thomas O. Hicks and Interim CEO James Silk converting $52.6 million of preferred units into Class A shares. The move aims to meet Nasdaq’s minimum equity rules after the company posted a Q1 FY2026 GAAP net loss of $7.19 per share. Zacks maintains a $2.00 price target, but ChartMill rates the company’s fundamentals 1/10.
22 October 2025
Vicor Stock Skyrockets to 52-Week High After Blockbuster Q3 and AI Licensing Boom

Vicor Stock Skyrockets to 52-Week High After Blockbuster Q3 and AI Licensing Boom

Vicor shares jumped to a 52-week high of $67.82 on Oct. 21 after Q3 revenue rose 18.5% to $110.4 million and EPS hit $0.63, beating estimates. Analyst upgrades followed, with price targets near $90. The company announced $300 million in licensing deals and launched new high-power modules. Vicor’s market cap stands at $2.9 billion with $362 million in cash and no debt.
AST SpaceMobile Stock Shoots for the Stars – Verizon Deal and Satellite Breakthroughs Ignite 300% Rally

AST SpaceMobile Stock Shoots for the Stars – Verizon Deal and Satellite Breakthroughs Ignite 300% Rally

AST SpaceMobile shares closed at $78.61 on Oct. 21, up nearly 300% in 2025 after briefly touching $99 mid-month. The company announced a Verizon partnership and completed the first 4G call via satellite with Bell Canada. CEO Abel Avellan says ASTS will launch up to 60 satellites by 2026. Analysts remain split on valuation, with short interest at 20% of float.
22 October 2025
Will SBEV Pop or Flop? Splash Beverage Group Stock Surges on Big Deals – Analysts Weigh In

Will SBEV Pop or Flop? Splash Beverage Group Stock Surges on Big Deals – Analysts Weigh In

Splash Beverage Group (NASDAQ: SBEV) closed at $1.89 on Oct. 21, 2025, down 1.6% for the day and up about 70% year-to-date, but far below its 52-week high near $13.59. The company regained NYSE American compliance in July after facing delisting. In July, Splash announced a $500,000 international order for its Pristine Costa Rica water. Insider filings show major warrant grants to top executives this summer.
22 October 2025
VSee Health (VSEE) Stock Skyrockets 75% on $10M Hospital Teleradiology Contract

VSee Health (VSEE) Stock Skyrockets 75% on $10M Hospital Teleradiology Contract

VSee Health shares jumped 94% to $0.945 on Oct. 21 after announcing a multi-year teleradiology contract with a major Level-1 trauma hospital system, expected to generate $10 million over two years. Q2 2025 revenue nearly doubled year-over-year to $3.4 million, driven by the iDoc Telehealth acquisition. Analyst ratings remain bullish, with targets as high as $5. Volatility persists as VSEE trades below $1.
22 October 2025
Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo Nordisk shares closed at $54.78 on Oct. 21, down nearly 50% in 2025 and wiping out about $70 billion in market value. The Novo Nordisk Foundation forced a board overhaul, with chair Helge Lund and six directors to be replaced. Novo announced deals to buy Akero for up to $5.2 billion and license Omeros’ OMS906 for up to $2.1 billion. U.S. price pressure and Eli Lilly’s competition have weighed on investor sentiment.
Vertiv (VRT) Stock Soars on AI Data-Center Boom and Blowout Q3 – Can the Rally Last?

Vertiv (VRT) Stock Soars on AI Data-Center Boom and Blowout Q3 – Can the Rally Last?

Vertiv shares are trading in the mid-$170s as of Oct. 22, 2025, up about 50% year-to-date after Q3 sales jumped 29% to $2.676 billion and diluted EPS more than doubled to $1.02. Organic orders surged nearly 60%, pushing backlog to $9.5 billion. Management raised 2025 guidance, now projecting up to $10.24 billion revenue and $4.10 adjusted EPS. The company credits AI and data-center demand for the surge.
Oklo Stock Soars 500% on $2B Nuclear Fuel Deal – Breakthrough or Bubble?

Oklo Stock Soars 500% on $2B Nuclear Fuel Deal – Breakthrough or Bubble?

Oklo Inc. shares surged over 600% in 2025 after announcing a $2 billion fuel partnership with Europe’s newcleo and Sweden’s Blykalla for U.S. nuclear fuel plants. The company raised $306 million via a SPAC merger in May 2024. Oklo signed 20-year power deals with Diamondback Energy and Wyoming Hyperscale. Analysts’ price targets lag current trading, citing early-stage risks.
GM Stock Skyrockets 15% on Earnings Beat – EV Pivot & Tariff Tailwinds

GM Stock Skyrockets 15% on Earnings Beat – EV Pivot & Tariff Tailwinds

GM shares surged about 15% to $67 on Oct. 22, 2025, near a 52-week high, after the company beat Q3 earnings and revenue estimates and raised 2025 guidance. GM took a $1.6 billion charge tied to slower EV demand and trimmed its EV expansion plans. New U.S. tariff policies will lower expected costs by up to $500 million. Analysts remain broadly positive, with most rating GM a Buy.
AT&T Beats Q3 Forecast with 405K New Subs – Is Its 5G Bet Paying Off?

AT&T Beats Q3 Forecast with 405K New Subs – Is Its 5G Bet Paying Off?

AT&T reported Q3 revenue of $30.7 billion, up 1.6% year-over-year, with GAAP EPS at $1.29 including a $5.5 billion DIRECTV gain. The company added 405,000 postpaid phone subscribers, beating expectations, and saw fiber net adds of 288,000. Mobility service revenue rose 2.3% to $16.9 billion; business wireline sales fell about 7.8%. Shares rose 4% pre-market as AT&T reaffirmed 2025 guidance and announced major spectrum and fiber acquisitions.
22 October 2025
Bahrain’s First Solar Power Plant: 150MW Tender to Power 6,300 Homes & Slash 100,000t CO₂

Bahrain’s First Solar Power Plant: 150MW Tender to Power 6,300 Homes & Slash 100,000t CO₂

Bahrain’s Electricity & Water Authority opened bidding for its first large-scale solar plant, a 150 MW PV project in Bilaj Al Jazayer, on October 16, 2025. The plant will cover 1.2 km², supply power for about 6,300 homes, and cut 100,000 tonnes of CO₂ yearly. Bids are due by December 28, with commercial operation targeted for Q3 2027. The project will more than double Bahrain’s current solar capacity.
1 74 75 76 77 78 148

Stock Market Today

  • Amazon's Steady Growth: The Boring Giant Compounding Value
    June 17, 2026, 3:31 AM EDT. Amazon (AMZN) continues to deliver consistent long-term growth, cementing its status as a 'boring giant' in the stock market. Despite lacking volatility, the company's ability to compound returns steadily appeals to investors prioritizing durability over rapid gains. The analysis, provided by a Senior Derivatives Expert with over a decade of experience, underscores Amazon's role in diverse multi-asset portfolios. Emphasizing the impact of macroeconomic trends and sector rotations, the report highlights the importance of risk-managed equity strategies using derivatives. The expert holds beneficial long positions in Amazon and Nvidia (NVDA), aligning with their investment thesis. This perspective supports confidence in Amazon's sustained compound growth amidst evolving market conditions.

Latest articles

Dow Closes at Record in After-Hours as S&P 500, Nasdaq Dip on Tech Slide

Dow Closes at Record in After-Hours as S&P 500, Nasdaq Dip on Tech Slide

17 June 2026
Dow hits second straight record close at 51,999.67 while S&P 500 and Nasdaq drop as tech stocks slide; Philadelphia semiconductor index plunges 5.7% and after-hours trading sees only slight gains for major index-tracking funds, as investors brace for Wednesday’s Fed decision and monitor inflation risks amid falling oil prices and a possible U.S.-Iran deal.
GD Culture shares drop on heavy trading and ongoing buyout uncertainty

GD Culture shares drop on heavy trading and ongoing buyout uncertainty

17 June 2026
GD Culture Group plunged 73.3% to $0.028 after heavy trading, putting fresh pressure on its unresolved, non-binding $10.75-per-share buyout proposal; risks include deal uncertainty, a $300 million share-sale program, and bitcoin-driven balance sheet swings, with no new company updates released Tuesday.
Go toTop